<p>Plates were coated with purified soluble E1 or E2 glycoprotein or NS3 of HCV as antigen to detect the specific humoral response against HCV. P24 antigen derived from HIV-1 was also coated as antigen to detect the antibody response against gag protein of lentiviral vector. Sera obtained 2 weeks after the indicated immunisation from each group and tested at a serial dilution. Bars represent the mean of six individual sera of each group; error bars represent the SEM. Significant p-values between the vaccinated groups are shown. *p<0.05, **p<0.01.</p
<p>Antibody immunoreactivity was analyzed by <i>assay type</i> for each HCV antigen. Two categories ...
International audienceAntibody responses to the hepatitis C virus (HCV) envelope proteins E1 and E2 ...
Abstract: Serum samples from 487 ambulatory I.V. drug users were screened for HIV and HCV antibodies...
<p>Sera obtained 2 weeks after the final immunisation were purified with protein G column and tested...
Recombinant autologous 212 1b (square symbol) and H77C (circle symbol) E1E2 lysates were either left...
Mean of serum antibody levels detected in all individuals at time-points 0, 20 PVD and 35 PVD, and 7...
Binding affinity of obtained anti-E2 antibodies to E2 proteins from (A) TH and (B) J6CF was analyzed...
Abstract Background All commercial Hepatitis C virus antibody (anti-HCV) assays use a combination of...
We have completed a phase 1 safety and immunogenicity trial with hepatitis C virus (HCV) envelope gl...
In this study, a 178 amino acids long portion of the hepatitis C virus (HCV) core gene was cloned se...
(A) Longitudinal anti-E2 (Left and Middle panels) and NS3 (Right) IgG responses in plasma measured b...
The hepatitis C virus (HCV) envelope glycoprotein E1E2 complex is a candidate vaccine antigen. Previ...
BACKGROUND: There is little information on the timing, magnitude, specificity, and clinical relevanc...
AbstractThe relatively high variability of the hepatitis C virus (HCV) envelope proteins E1 and E2 s...
An enzyme immunoassay (EIA) which utilizes a solid phase coated with a recombinant antigen (c100-3) ...
<p>Antibody immunoreactivity was analyzed by <i>assay type</i> for each HCV antigen. Two categories ...
International audienceAntibody responses to the hepatitis C virus (HCV) envelope proteins E1 and E2 ...
Abstract: Serum samples from 487 ambulatory I.V. drug users were screened for HIV and HCV antibodies...
<p>Sera obtained 2 weeks after the final immunisation were purified with protein G column and tested...
Recombinant autologous 212 1b (square symbol) and H77C (circle symbol) E1E2 lysates were either left...
Mean of serum antibody levels detected in all individuals at time-points 0, 20 PVD and 35 PVD, and 7...
Binding affinity of obtained anti-E2 antibodies to E2 proteins from (A) TH and (B) J6CF was analyzed...
Abstract Background All commercial Hepatitis C virus antibody (anti-HCV) assays use a combination of...
We have completed a phase 1 safety and immunogenicity trial with hepatitis C virus (HCV) envelope gl...
In this study, a 178 amino acids long portion of the hepatitis C virus (HCV) core gene was cloned se...
(A) Longitudinal anti-E2 (Left and Middle panels) and NS3 (Right) IgG responses in plasma measured b...
The hepatitis C virus (HCV) envelope glycoprotein E1E2 complex is a candidate vaccine antigen. Previ...
BACKGROUND: There is little information on the timing, magnitude, specificity, and clinical relevanc...
AbstractThe relatively high variability of the hepatitis C virus (HCV) envelope proteins E1 and E2 s...
An enzyme immunoassay (EIA) which utilizes a solid phase coated with a recombinant antigen (c100-3) ...
<p>Antibody immunoreactivity was analyzed by <i>assay type</i> for each HCV antigen. Two categories ...
International audienceAntibody responses to the hepatitis C virus (HCV) envelope proteins E1 and E2 ...
Abstract: Serum samples from 487 ambulatory I.V. drug users were screened for HIV and HCV antibodies...